Meta-analysis of 8 observational studies in adults aged 60 or over: RSVpreF and RSVpreF3 vaccination was associated with lower odds of RSV-related hospitalisation (OR 0.23) and ED visits (OR 0.23); protection against hospitalisation was lower in immunocompromised adults.
Meta-analysisn = 8 studies
Sumsuzzman et al. Real-World Effectiveness of RSVpreF and RSVpreF3 Vaccines in Preventing Hospitalization and Emergency Department Visits Associated With Respiratory Syncytial Virus in Older Adults: A Meta-analysis